Condensed Consolidated Statement of Earnings - USD ($) shares in Thousands, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Net sales	$ 12,593	$ 11,142	$ 23,757	$ 21,500
Cost of products sold, excluding amortization of intangible assets	5,325	4,854	10,215	9,322
Amortization of intangible assets	658	420	1,080	840
Research and development	892	725	1,659	1,441
Selling, general, and administrative	4,025	3,091	7,765	6,152
Total operating cost and expenses	10,900	9,090	20,719	17,755
Operating earnings	1,693	2,052	3,038	3,745
Interest expense	351	121	525	252
Interest (income)	(52)	(71)	(158)	(153)
Net foreign exchange (gain) loss	4	(11)	(9)	(18)
Other (income) expense, net	(134)	(137)	(293)	(264)
Earnings before taxes	1,524	2,150	2,973	3,928
Taxes on earnings	596	371	968	824
Net Earnings	$ 928	$ 1,779	$ 2,005	$ 3,104
Basic Earnings Per Common Share (in dollars per share)	$ 0.53	$ 1.02	$ 1.15	$ 1.78
Diluted Earnings Per Common Share (in dollars per share)	$ 0.53	$ 1.01	$ 1.14	$ 1.77
Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares)	1,740,420	1,743,437	1,741,438	1,741,348
Dilutive Common Stock Options (in shares)	2,561	7,398	3,576	7,706
Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options (in shares)	1,742,981	1,750,835	1,745,014	1,749,054
Outstanding Common Stock Options Having No Dilutive Effect (in shares)	11,873	1,442	9,900	1,431

Condensed Consolidated Statement of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash Flow From (Used in) Operating Activities:
Net earnings	$ 2,005	$ 3,104
Adjustments to reconcile net earnings to net cash from operating activities —
Depreciation	783	693
Amortization of intangible assets	1,080	840
Share-based compensation	485	431
Trade receivables	(428)	(672)
Inventories	(721)	(252)
Other, net	599	(680)
Net Cash From Operating Activities	3,803	3,464
Cash Flow From (Used in) Investing Activities:
Acquisitions of property and equipment	(896)	(986)
Acquisitions of businesses and technologies, net of cash acquired	(19,962)	(30)
Sales (purchases) of other investment securities, net	(187)	(44)
Other	48	8
Net Cash From (Used in) Investing Activities	(20,997)	(1,052)
Cash Flow From (Used in) Financing Activities:
Net borrowings (repayments) of short-term debt and other	95	(52)
Proceeds from issuance of long-term debt	19,827	3
Repayments of long-term debt	(2,821)	(1,002)
Purchases of common shares	(1,225)	(286)
Proceeds from stock options exercised	119	322
Dividends paid	(2,200)	(2,055)
Other	0	(82)
Net Cash From (Used in) Financing Activities	13,795	(3,152)
Effect of exchange rate changes on cash and cash equivalents	(19)	75
Net Increase (Decrease) in Cash and Cash Equivalents	(3,418)	(665)
Cash and Cash Equivalents, Beginning of Year	8,522	7,616
Cash and Cash Equivalents, End of Period	$ 5,104	$ 6,951

Condensed Consolidated Balance Sheet - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Current Assets:
Cash and cash equivalents	$ 5,104	$ 8,522
Short-term investments	499	417
Trade receivables, less allowances of $486 in 2026 and $490 in 2025	8,599	7,929
Inventories:
Finished products	4,512	3,976
Work in process	1,023	904
Materials	1,780	1,608
Total inventories	7,315	6,488
Prepaid expenses and other receivables	3,000	2,640
Total Current Assets	24,517	25,996
Investments	1,111	918
Property and equipment, at cost	26,469	25,222
Less: accumulated depreciation and amortization	13,657	13,406
Net property and equipment	12,812	11,816
Intangible assets, net of amortization	17,211	5,526
Goodwill	35,244	24,035
Deferred income taxes and other assets	18,320	18,422
Total Assets	109,215	86,713
Current Liabilities:
Trade accounts payable	4,794	4,240
Salaries, wages, and commissions	1,619	1,745
Other accrued liabilities	6,892	5,812
Dividends payable	1,093	1,097
Income taxes payable	411	569
Current portion of long-term debt	3,005	3,033
Total Current Liabilities	17,814	16,496
Long-term debt	29,603	9,896
Post-employment obligations, deferred income taxes, and other long-term liabilities	10,036	7,550
Commitments and Contingencies
Shareholders’ Investment:
Preferred shares, one dollar par value Authorized — 1,000,000 shares, none issued	0	0
Common shares, without par value Authorized — 2,400,000,000 shares Issued at stated capital amount — Shares: 2026: 1,998,291,279; 2025: 1,996,795,525	25,495	25,527
Common shares held in treasury, at cost — Shares: 2026: 267,907,258; 2025: 260,196,074	(17,967)	(17,177)
Earnings employed in the business	49,794	49,781
Accumulated other comprehensive income (loss)	(6,212)	(6,001)
Total Abbott Shareholders’ Investment	51,110	52,130
Noncontrolling interests	652	641
Total Shareholders’ Investment	51,762	52,771
Total Liabilities and Shareholders' Investment	$ 109,215	$ 86,713